[ad_1]
1 hour ago
Novo Nordisk’s market capitalization surpasses Tesla’s on obesity drug trial data
Jonathan Ra | Null Photo | Getty Images
Wegoby’s obesity drug maker Novo Nordisk has surpassed Tesla in market value after new early trial data for a new experimental weight loss drug showed positive results.
The Danish company’s shares hit an all-time high on Thursday, rising as much as 8% after telling investors that a Phase 1 clinical trial of its Amicletin tablets showed participants lost 13.1% of their body weight after 12 weeks. did.
Novo Nordisk is now the world’s 12th most valuable company with a market capitalization of $604 billion, ahead of Tesla’s $569 billion, according to FactSet data.
Shares were slightly lower on Friday, down 0.7% by 11am London time.
— Karen Gilchrist
3 hours ago
Stocks are on the rise: Grifols up 17%, HelloFresh down 44%
According to Reuters, Spanish pharmaceutical company Grifols soared 17% after announcing its 2023 financial results, which were approved by auditing firm KPMG with an unqualified opinion.
The beleaguered company has been battling wild swings in its stock price following a January report from Gotham City Research that questioned its financial accounting. A second report by short sellers on Thursday questioned the company’s transparency, sending the stock down 15%.
Meanwhile, food delivery company HelloFresh plunged 44% after its latest financial report predicted a decline in profits in 2024.
— Karen Gilchrist
4 hours ago
German industrial production increases in January
New data on Friday showed German industrial production rose 1% in January, beating expectations of 0.5%.
Production in construction and manufacturing also increased by 2.7% and 1.1%, respectively, giving a slight boost to Germany’s lackluster economy.
— Karen Gilchrist
12 hours ago
CNBC Pro: These stocks are already up in 2023, but Goldman Sachs says they still have more than 30% upside potential.
Stocks are set to perform well in 2023, and the market remains hot so far this year.
The S&P 500 surged about 24% in 2023, recovering from the 2022 bear market. Stocks around the world also rose, with the FTSE All World Ex US index up his 16.2% in 2023.
CNBC Pro thoroughly examines Goldman’s analyst research and the latest global conviction list, and based on the bank’s latest price target, we see a strong upside in 2023, but a We found stocks that still have more than 30% upside potential.
CNBC Pro subscribers can read more here.
— Tan Weizhen
12 hours ago
CNBC Pro: Missed the Nvidia rally? These 10 companies are buying the company’s chips and the stock is rising
Nvidia’s stock has risen 280% over the past year, thanks to soaring sales of chips that power artificial intelligence applications.
But Silicon Valley companies aren’t the only ones participating in AI-powered gatherings. Investors are also pouring money into companies buying these chips amid hopes that AI will help improve productivity and profits.
CNBC Pro subscribers can read about Nvidia customers whose stock is rising.
— Ganesh Rao
5 hours ago
Click here for opening call
European markets are expected to open higher on Friday.
According to IG data, the UK’s FTSE 100 index rose 5 points to 7,702, Germany’s DAX rose 31 points to 17,891, France’s CAC rose 13 points to 8,036 and Italy’s FTSE MIB rose 62 points. It is expected to start at 33,485.
On the earnings side, Europai, Cepsa, Royal London Group and Informa are scheduled to announce their results.
— Karen Gilchrist
[ad_2]
Source link
